The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: Preclinical mouse model and phase I/IIa clinical study.
 
Myeong Geun Choi
No Relationships to Disclose
 
Gun Woo Son
No Relationships to Disclose
 
Dae-Hyun Ko
No Relationships to Disclose
 
Wonjun Ji
No Relationships to Disclose
 
Jin Kyung Rho
No Relationships to Disclose
 
Jae Cheol Lee
No Relationships to Disclose
 
Yong Man Kim
Employment - NKMax
 
Jae Seob Jung
Employment - NKMAX
 
Paul Y. Song
Employment - NkGen Biotech
Leadership - NkGen Biotech
Stock and Other Ownership Interests - NkGen Biotech
Consulting or Advisory Role - Pepromene
 
Byeong Gon Yoon
No Relationships to Disclose
 
Jong-min Jo
No Relationships to Disclose
 
Mi Young Choi
No Relationships to Disclose
 
Chang-Min Choi
Employment - Procuratio
Leadership - Procuratio
Stock and Other Ownership Interests - Procuratio
Consulting or Advisory Role - Qurient
Speakers' Bureau - AstraZeneca; Yuhan
Research Funding - Yuhan
Travel, Accommodations, Expenses - Qurient